Quarterly Updates30 May 2026, 07:43 pm
Aarey Drugs: FY26 Revenue ₹473.94 Mn, PAT ₹39.67 Mn
AI Summary
Aarey Drugs & Pharmaceuticals Ltd's board approved the audited standalone financial results for the fourth quarter and year ended March 31, 2026. The company reported revenue from operations of ₹473.94 million and a profit after tax of ₹39.67 million for the year ended March 31, 2026. The board meeting, held on May 30, 2026, also took on record the statement of deviation or variation in utilization of funds raised through convertible warrants.
Key Highlights
- Aarey Drugs approved audited standalone financial results for FY26.
- FY26 revenue from operations stood at ₹473.94 million.
- FY26 profit after tax was reported as ₹39.67 million.
- The board approved a statement of deviation in fund utilization.
- Trading window will open 48 hours after the results announcement.
Price Impact
More from AREYDRG